ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
82.765
0.00%
US Dollar vs AUD
1.514
-0.05%
Bitcoin
63,270.38
0.61%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Akebia Therapeutics Inc (AKBA)

  7. Akebia Therapeutics Inc (AKBA) News

AKBA

Akebia Therapeutics (AKBA)

Akebia Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AKBA
DateTimeSourceHeadlineSymbolCompany
02/05/202422:30PR Newswire (US)Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business HighlightsNASDAQ:AKBAAkebia Therapeutics Inc
02/05/202406:05PR Newswire (US)Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AKBAAkebia Therapeutics Inc
03/04/202407:05PR Newswire (US)Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AKBAAkebia Therapeutics Inc
28/03/202411:26PR Newswire (US)Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on DialysisNASDAQ:AKBAAkebia Therapeutics Inc
15/03/202407:15PR Newswire (US)Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:AKBAAkebia Therapeutics Inc
12/03/202408:05PR Newswire (US)Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:AKBAAkebia Therapeutics Inc
02/03/202409:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
02/03/202409:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
02/03/202409:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
02/03/202409:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
02/03/202408:05PR Newswire (US)Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AKBAAkebia Therapeutics Inc
01/03/202410:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
01/03/202410:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
01/03/202410:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
01/03/202410:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
01/03/202408:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
01/03/202408:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
01/03/202408:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
28/02/202410:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
28/02/202410:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
28/02/202410:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
28/02/202410:11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
14/02/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKBAAkebia Therapeutics Inc
03/02/202408:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
03/02/202408:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
03/02/202408:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
03/02/202408:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
03/02/202408:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
03/02/202408:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
03/02/202408:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKBAAkebia Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AKBA

Your Recent History

NYSE
JPM
JP Morgan Chase
ASX
XFL
S&P ASX 50
ASX
ORG
Origin Energy
ASX
SUN
Suncorp
ASX
XJO
S&P ASX 200
ASX
WOW
Woolworths
ASX
NAB
National Australia Bank
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
AMP
AMP
NASDAQ
GOOGL
Alphabet
ASX
XAO
Australian SE All Ordina...
NYSE
DIS
Walt Disney
NYSE
VZ
Verizon Communications
ASX
NCM
Newcrest Mining
ASX
BHP
BHP
ASX
MQG
Macquarie
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved